NCT00914524View on ClinicalTrials.gov

Study of Olmesartan Medoxomil (CS-866) in Patients With Chronic Glomerulonephritis or Diabetic Nephropathy

PHASE2CompletedINTERVENTIONAL
Enrollment

49

Participants

Timeline

Start Date

January 31, 2005

Primary Completion Date

April 30, 2006

Study Completion Date

October 31, 2006

Conditions
Chronic GlomerulonephritisDiabetic Nephropathy
Interventions
DRUG

olmesartan medoxomil

olmesartan medoxomil tablets, once daily

Trial Locations (1)

Unknown

Tokyo

Sponsors
All Listed Sponsors
lead

Daiichi Sankyo Co., Ltd.

INDUSTRY